NOVAGENIX BIOANALYTICAL DRUG R&D

NOVAGENIX BIOANALYTICAL DRUG R&D is neither a traditional factory nor a trading company. It is a Contract Research Organization (CRO) specializing in research and development services.

Company Introduction:

NOVAGENIX BIOANALYTICAL DRUG R&D is a Contract Research Organization (CRO) based in Turkey, dedicated to providing specialized services primarily in bioanalysis and drug development. The company serves pharmaceutical, biotechnology, and medical device industries by conducting essential research activities required for the development and regulatory approval of new drugs and therapies.

NOVAGENIX focuses on a range of R&D services including method development and validation, quantitative determination of drugs and their metabolites in biological samples, and pharmacokinetic and pharmacodynamic studies. They play a critical role in supporting non-clinical and clinical trials by generating high-quality scientific data. Their work is centered on scientific research, data generation, and contributing to the acceleration of the drug development process, ensuring scientific rigor and compliance with regulatory standards.

NOVAGENIX BIOANALYTICAL DRUG R&D, based in Turkey, primarily offers specialized services in drug development and bioanalysis as a Contract Research Organization (CRO). They do not manufacture or sell pharmaceutical products directly to the market.

Their main services include:

Bioanalytical Services

Method Development and Validation

Sample Analysis (for various biological matrices such as plasma, serum, urine, tissue)

Pharmacokinetic (PK) and Toxicokinetic (TK) Studies

Bioequivalence (BE) Studies

Drug Metabolism and Pharmacokinetics (DMPK) Studies

In Vitro ADME (Absorption, Distribution, Metabolism, Excretion) Studies

Pre-clinical and Clinical Bioanalysis

Biomarker Analysis

Immunogenicity Testing